Information Library
Results for: Oncology - Business transformation
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
Reinventing Biopharma
White Paper — February 1, 2012
The biopharmaceutical industry today is facing a multifaceted “value challenge.” -
Quintiles Forms New Biomarker Research and Development Company
Press Release — January 18, 2012 – Quintiles announced that it has invested in a new company formed to provide oncology consulting services and new cancer biomarkers, the key to scientific selection of the right drug for the right patient.
-
Clinical – Smarter Trials, Accelerated Outcomes
Brochure — February 16, 2011
Quintiles will work with you to plan and execute the smartest clinical trials and post-marketing studies, informed by a holistic view of strategic, operational, regulatory and marketplace issues. -
Commercial – Identify, Promote and Prove Treatment Value
Brochure — April 1, 2010
Quintiles has built an unmatched suite of commercial competencies that biopharma companies are leveraging for faster market access and sustained success. -
Tissue Biomarkers and Digital Pathology in Oncology Clinical Development
Presentation — March 26, 2010
Tissue Biomarkers & Digital Pathology in Oncology Clinical Development presented by Christopher Ung, VP Strategic Business & Operations, Oncology at Asia Pharma in March 2010. -
Tissue Biomarkers and Digital Pathology in Oncology Clinical Development
Presentation — March 26, 2010
Tissue Biomarkers & Digital Pathology in Oncology Clinical Development presented by Christopher Ung, VP Strategic Business & Operations, Oncology at Asia Pharma in March 2010. -
Tissue Biomarkers in Oncology Clinical Development: The Digital Advantage
Presentation — September 15, 2009
The advantages of incorporating digital pathology into your oncology clinical development process.
Page 1 of 1 (7 results)
